IL4 and major depressive disorder: The present study revealed a significantly decreased IL-4 levels following cycles of chemotherapy and a negative correlation with PHQ-9 scores align with studies suggesting that major depression in cancer patients may be linked to inadequately controlled inflammation related to the disease.